title: Hyperpigmentation of the face following adalimumab treatment.
authors.forename: Maria
authors.initials: M
authors.lastname: Blomberg
authors.forename: Claus O C
authors.initials: CO
authors.lastname: Zachariae
authors.forename: Frederik
authors.initials: F
authors.lastname: Grønhøj
mesh_terms: D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000009:adverse effects*; D015535:Arthritis, Psoriatic / Q000188:drug therapy*; D005145:Face; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D012880:Skin Pigmentation / Q000187:drug effects*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D000068879:Adalimumab